NEXO
20+ leading crypto organizations including BTC Inc, Bitget, Brink, Chainalysis, Hacken, Nansen, and Unstoppable Domains have come together for the 'Bitcoin Deserves an Emoji' movement, initiated by Nexo. Uniting the global crypto community, the initiative aims to introduce a Bitcoin emoji to any digital keyboard and emphasize cryptocurrency's triple identity as money, technology, and culture in today’s society.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312299831/en/
Uniting the global crypto community, the 'Bitcoin Deserves an Emoji' initiative aims to introduce a Bitcoin emoji to any digital keyboard and emphasize cryptocurrency's triple identity as money, technology, and culture in today’s society. (Graphic: Business Wire)
This community-driven initiative starts with a 50-day petition on Change.org, followed by an official proposal to the Unicode Consortium during the 2024 submission window. The new, widespread effort for a Bitcoin emoji, once turned down in 2020, shows just how important blockchain has become in our daily lives.
Celebrating Community, Culture, and Collective Values
92% of internet users worldwide use emojis in their digital communications, according to Unicode. Originating in Japan in the 1990s, emojis have transformed from niche pictographs to key elements of online conversations, transcending language and borders to reflect our values, innovations, and contemporary culture. Similarly, Bitcoin, beyond being a mere asset, displays the technological breakthrough of blockchain, embodying principles of decentralization, transparency, and security. Its inclusion as an emoji would not only symbolize its indispensable role in today's digital and financial landscapes but also ensure Bitcoin is recognized as an integral part of daily life across the globe.
Voices of the Movement
Already gaining substantial traction, the Bitcoin Emoji Initiative showcases the unity within the cryptocurrency community and the shared goal of further establishing Bitcoin's presence in our cultural landscape.
“Bitcoin's journey reflects a remarkable blend of innovation and community. It's time its significance is recognized universally, starting with a symbol we all understand - an emoji. Join us in making history,” said Kosta Kantchev, Co-founder & Executive Chairman of Nexo.
“Bitcoin is universal money for the world, it needs a universal emoji for every person, young and old to use,” said David Bailey, CEO of BTC Inc.
“Supporting Bitcoin's development has always been about changing the world through code. An official emoji is a nod to Bitcoin's technological impact on the world.” said Mike Schmidt, Executive Director of Brink.
"Bitget recognizes the significance of having a Bitcoin emoji as a universal symbol of digital assets in our everyday communication. This initiative aligns with our mission to promote crypto adoption and accessibility. We wholeheartedly support this endeavor and believe it will contribute further to mainstream acceptance of the whole industry. Together with our partners and the wider crypto community, we are committed to advocating for the inclusion of a Bitcoin emoji on keyboards worldwide,” said Gracy Chen, Managing Director of Bitget.
"We fully support Nexo's petition as this initiative to create a Bitcoin Emoji aligns perfectly with Nansen's commitment to fostering a more inclusive and expressive crypto environment”, said Alex Svanevik, CEO and co-founder of Nansen.
“For a decade, Chainalysis has been dedicated to fostering trust in blockchains while aiding the advancement of the web3 ecosystem and assisting public sector entities in staying abreast of crypto developments. As a trailblazer in blockchain analysis, we've safeguarded and championed Bitcoin since its inception. We commend Nexo's advocacy for acknowledging a cultural symbol—the Bitcoin emoji—a testament to the era we inhabit”, said Ian Andrews, CMO of Chainalysis.
"The definition of an emoji is a small digital image or icon used to express an idea. Bitcoin is now a well-known idea across all countries. CryptoQuant fully supports Nexo's initiative to facilitate the global mass adoption of Bitcoin," said CryptoQuant's CEO Ki Young Ju.
“The Bitcoin emoji reflects the essence of decentralization, representing a collective movement towards a more open and inclusive financial future for everyone. We align with Nexo's Bitcoin Emoji petition,” said Sam Lekhak, Head of Marketing & Comms at Liquity.
“We're thrilled to stand alongside industry leaders in championing a Bitcoin emoji, a move poised to give identity to the industry while also serving as a bridge between technical innovation and cultural expression,” said Sandy Carter, COO, Unstoppable Domains
Join the Movement
Everyone is invited to be part of this historic community-driven initiative. By signing the Change.org petition and advocating for the Bitcoin emoji, everyone can contribute to celebrating Bitcoin's legacy and future. For more information and to join the campaign, visit bitcoinemoji.org.
About the Initiative
This initiative is a collaborative effort by 20+ leading organizations in the cryptocurrency space, united by a common goal to promote understanding, adoption, and technological progress of digital currencies. Participating organizations: Nexo, Brink, Bitget, Chainalysis, Polygon, Brave, BTC Inc, Hacken, CryptoQuant, Nansen, Unstoppable Domains, Liquity, Mara, Busha, Zulu, Cadenza, Bware Labs, Meta4 Capital, Sift, MarketAcross, Bitcompare, Bithomp, Milkroad, Crypto Oasis.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240312299831/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom